Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
Trinity Biotech plc - American Depositary Shares (TRIB)
Last trinity biotech plc - american depositary shares earnings: 10/26 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
trinitybiotech.com/investor-relations
Company Research
Source: GlobeNewswire
DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the appointment of Avinash Kale as Continuous Glucose Monitor (CGM) Programme Director. His appointment is a critical step forward in advancing the Company’s recently acquired CGM technology and in driving its innovation and development to bring an advanced CGM solution to the global market. “We are very excited to welcome Avinash to Trinity Biotech, where he will be instrumental in advancing our mission of introducing intelligent wearable biosensors, including CGMs, into markets all around the globe. I believe that Avinash will bring a new level of knowledge and experience in the design and large-scale manufacture of advanced MedTech devices to this exciting project,” said John Gillard, Chief Executive Officer. “Our plan is to expand the usage of
Show less
Read more
Impact Snapshot
Event Time:
TRIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRIB alerts
High impacting Trinity Biotech plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TRIB
News
- Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAIGlobeNewswire
- Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesGlobeNewswire
- Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development [Yahoo! Finance]Yahoo! Finance
- Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
TRIB
Sec Filings
- 5/16/24 - Form 6-K
- 5/8/24 - Form EFFECT
- 5/7/24 - Form 424B3
- TRIB's page on the SEC website